Generalized Anxiety Disorder: Clinical Trials

509 trials for Generalized Anxiety Disorder, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

290 completed, 75 recruiting, 48 unknown, 29 not yet recruiting. 277 Not applicable, 70 Phase 3, 50 Phase 2, 40 Phase 4, 20 Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable277Completed 148, Recruiting 43, Unknown 32, Not yet recruiting 20, Active not recruiting 14, Terminated 13, Withdrawn 5, Enrolling by invitation 2
Phase 370Completed 45, Recruiting 9, Terminated 6, Unknown 4, Active not recruiting 3, Withdrawn 2, Not yet recruiting 1
Phase 250Completed 35, Recruiting 8, Terminated 3, Withdrawn 2, Active not recruiting 1, Unknown 1
Phase 440Completed 34, Terminated 4, Active not recruiting 1, Recruiting 1
Phase 120Completed 13, Terminated 3, Not yet recruiting 1, Recruiting 1, Unknown 1, Withdrawn 1
Early Phase 11Unknown 1

Follow Generalized Anxiety Disorder: new trials by email Literature Review of Generalized Anxiety Disorder trials Research Report on Generalized Anxiety Disorder

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Qualitative Study of Student Financial Insecurity and Psychiatry
Semi-structured interviews - Depressive Disorder, Generalized Anxiety Disorder
Not yet recruitingAssistance Publique - Hôpitaux de Paris302027-01-012026-08-05
CannaRiver CBD Calm for Anxiety, Sleep, and Well-Being in Adults With Generalized Anxiety Disorder
Cannabidiol (CBD) With Cannabinol (CBN) and Cannabigerol (CBG) Oral Tincture (CannaRiver CBD Calm) - Generalized Anxiety Disorder
Not applicableNot yet recruitingAssociação Pan-Americana Multidisciplinar de Endocanabinologia602026-11-012026-09-18
A Trial of the Safety and Tolerability of SEP-363856 in Adults With Generalized Anxiety Disorder
SEP-363856 - Generalized Anxiety Disorder
Phase 3RecruitingOtsuka Pharmaceutical Development & Commercialization, Inc.11202026-10-082026-10-20
LIFU for Chronic Pain and Generalized Anxiety Disorder
Low Intensity Focused Ultrasound - Chronic Pain, Generalized Anxiety Disorder
Not applicableNot yet recruitingVirginia Polytechnic Institute and State University102026-10-012026-09-11
A Study of JNJ-99245354 (ITI-1284) as an Adjunctive Treatment in Participants With Generalized Anxiety Disorder (GAD) Who Have an Inadequate Response to GAD Treatment
JNJ-99245354, Placebo - Generalized Anxiety Disorder
Phase 3Not yet recruitingIntra-Cellular Therapies, Inc.7052026-09-302026-10-02
Group Transdiagnostic Cognitive Behavioural Therapy for Intolerance of Uncertainty Versus Applied Relaxation
Group Transdiagnostic Cognitive Behavioural Therapy for Intolerance of Uncertainty (CBT-IU), Group Transdiagnostic Applied Relaxation (AR) - Mental Disorders, Mood Disorders
Not applicableNot yet recruitingMedical Research Council Cognition and Brain Sciences Unit1352026-09-212026-10-08
Miles for Mental Health
Exercise - Generalized Anxiety Disorder (GAD), Depressive and Anxiety Disorders
Not applicableNot yet recruitingEmporia State University202026-09-102026-09-11
Device for Treating Generalized Anxiety
EXOMIND (BTL-699-2) Active treatment, EXOMIND (BTL-699-2) Sham treatment - Generalized Anxiety Disorder (GAD)
Not applicableRecruitingBTL Industries Ltd.402026-09-092026-09-18
Continuous Theta Burst Stimulation for Generalized Anxiety Disorder
Continuous Theta Burst Stimulation of the Right Posterior Parietal Cortex, Continuous Theta Burst Stimulation of the Right Dorsolateral Prefrontal Cortex - Generalized Anxiety Disorder
Not applicableRecruitingMilitary Hospital 175402026-09-092026-09-10
A Study to Asses Safety and Tolerability of ITI-1284 Given Alone or as an Additional Treatment in Participants With Generalized Anxiety Disorder (GAD)
ITI-1284 - Generalized Anxiety Disorder
Phase 3RecruitingIntra-Cellular Therapies, Inc.9002026-09-032026-09-29
Student Precarity and Psychiatry
Questionnaires - Depressive Disorder, Major, Generalized Anxiety Disorder
Not yet recruitingAssistance Publique - Hôpitaux de Paris450002026-09-012026-06-15
Acupuncture for Generalized Anxiety Disorder
sham electro-acupuncture, 2Hz electro-acupuncture, 100Hz electro-acupuncture - Generalized Anxiety Disorder (GAD)
Not applicableNot yet recruitingSecond Affiliated Hospital, Zhejiang University, School of Medicine1202026-09-012026-09-02
Non-Coding RNAs Gene Expression in Psychiatric Disorders
Reverse Transcription Quantitative Polymerase Chain Reaction - Schizophrenia Disorders, Major Depression
Not yet recruitingCarmen Concerto3842026-09-012026-06-23
A Trial of the Efficacy and Safety of a Fixed Dose of SEP-363856 in Adults With Generalized Anxiety Disorder
SEP-363856, Placebo - Generalized Anxiety Disorder
Phase 3RecruitingOtsuka Pharmaceutical Development & Commercialization, Inc.3842026-08-062026-10-20
Multimodal Cohort Study of Generalized Anxiety Disorder
Generalized Anxiety Disorder (GAD)
Not yet recruitingShanghai Mental Health Center4002026-08-012026-08-13
A Trial of the Efficacy and Safety of Fixed Doses of SEP-363856 in Adults With Generalized Anxiety Disorder
SEP-363856, Placebo - Generalized Anxiety Disorder
Phase 3RecruitingOtsuka Pharmaceutical Development & Commercialization, Inc.5762026-07-282026-09-22
Serotonin Variants & Gut Microbiota in Mental Health
SNP Genotyping and Gut Metagenomics - Major Depressive Disorder (MDD, Anxiety Disorder, Generalized
Not yet recruitingNeurobiologix302026-07-012026-06-10
Efficacy of Expectancy Focused Exposure Therapy for Anxiety Disorders
Expectancy Focused Exposure, Anxiety Focused Exposure - Anxiety Disorders, Panic Disorder
Not applicableRecruitingUniversity of Chile2032026-07-012026-08-07
Evaluate the Beneficial Effects of an Oral Nutritional Supplement Based on Leonurus Cardiaca for the Improvement of Mood and Anxiety
Leonurus cardiaca extract 250 mg, Placebo, Leonurus cardiaca extract 500 mg - General Anxiety Disorder
Not applicableNot yet recruitingAzienda di Servizi alla Persona di Pavia602026-06-152025-11-25
Transcranial Alternating Current Stimulation to Enhance Mindfulness Therapy in Generalized Anxiety Disorder
Synchronous Individualized Alpha-Frequency tACS, Desynchronous Individualized Alpha-Frequency tACS, Sham tACS - Generalized Anxiety Disorder (GAD)
Not applicableNot yet recruitingCentral South University992026-06-012026-06-16

Showing 20 of 509. Sign in to see all of them.

Narrower conditions

Anxiety Disorders (228)  ·  Phobia, Social (119)  ·  Panic Disorder (106)  ·  Depression (68)  ·  Depressive Disorder, Major (66)  ·  Obsessive-Compulsive Disorder (53)  ·  Anxiety, Separation (48)  ·  Stress Disorders, Post-Traumatic (41)  ·  Agoraphobia (30)  ·  Phobia, Specific (28)  ·  Bipolar Disorder (21)  ·  Psychological Well-Being (17)  ·  Mood Disorders (13)  ·  Mental Disorders (12)

Broader conditions

Mental Disorders (497)  ·  Anxiety Disorders (281)  ·  Phobic Disorders (110)  ·  Behavior (94)  ·  Mood Disorders (87)  ·  Behavioral Symptoms (74)  ·  Depressive Disorder (67)  ·  Neurodevelopmental Disorders (61)  ·  Trauma and Stressor Related Disorders (42)  ·  Stress Disorders, Traumatic (40)  ·  Pathological Conditions, Signs and Symptoms (31)  ·  Nervous System Diseases (27)  ·  Signs and Symptoms (25)  ·  Bipolar and Related Disorders (20)  ·  Neurologic Manifestations (17)

Interventions

Cognitive Behavioral Therapy (44)  ·  Therapeutics (16)  ·  imagabalin (10)  ·  Escitalopram (9)  ·  Paroxetine (9)  ·  Quetiapine Fumarate (8)  ·  Duloxetine Hydrochloride (7)  ·  Transcranial Magnetic Stimulation (7)  ·  Exercise (6)  ·  Sertraline (6)  ·  Waiting Lists (6)  ·  Vortioxetine (5)  ·  Alprazolam (4)  ·  Cannabidiol (4)  ·  Lorazepam (4)

Sponsors

Pfizer (12)  ·  Baylor College of Medicine (11)  ·  Karolinska Institutet (11)  ·  Massachusetts General Hospital (11)  ·  AstraZeneca (9)  ·  University of South Florida (9)  ·  University of Pennsylvania (7)  ·  NYU Langone Health (6)  ·  Otsuka Pharmaceutical Development & Commercialization, Inc. (6)  ·  University of California, Los Angeles (6)  ·  AbbVie (5)  ·  Georgetown University (5)  ·  Laureate Institute for Brain Research, Inc. (5)  ·  University of Pittsburgh (5)  ·  Babes-Bolyai University (4)

Countries

United States (263)  ·  Canada (50)  ·  Sweden (23)  ·  China (22)  ·  United Kingdom (15)  ·  France (11)  ·  Germany (11)  ·  Romania (10)  ·  Russia (10)  ·  Turkey (Türkiye) (10)  ·  Mexico (9)  ·  Norway (8)  ·  Poland (8)  ·  Spain (8)  ·  Finland (7)

Top investigators

Eric A Storch, Ph.D. (4)  ·  Alexander Bystritsky, MD (3)  ·  Arun Ravindran, MD, PhD (3)  ·  Giovanna Forero, MA (3)  ·  Gretchen J Diefenbach, Ph.D. (3)  ·  Michael Van Ameringen, MD, FRCPC (3)  ·  Michel J. Dugas, Ph.D. (3)  ·  Michelle G. Newman, PhD (3)  ·  Anca Dobrean, Ph.D. (2)  ·  Asle Hoffart, PhD (2)

Results publications

PMID 22143997, PMID 24394383, PMID 27486544, PMID 18974308, PMID 24565357, PMID 25721183, PMID 29081307, PMID 34197151, PMID 34693989, PMID 41730563, PMID 42574109, PMID 10193207, PMID 11952187, PMID 12567277, PMID 1409977, PMID 15337269, PMID 15902586, PMID 16142633, PMID 16320215, PMID 16330721, PMID 16360929, PMID 16441069, PMID 16540816, PMID 16876832, PMID 16930894, PMID 17316822, PMID 17562493, PMID 18176908, PMID 18348596, PMID 18373143, PMID 18458207, PMID 18572984, PMID 19042026, PMID 19155456, PMID 19204653, PMID 19212970, PMID 19317960, PMID 19351943, PMID 19592748, PMID 19593179, PMID 19691907, PMID 19745648, PMID 19829198, PMID 19881891, PMID 19915521, PMID 20051130, PMID 20146834, PMID 20206470, PMID 20455246, PMID 20483968

NIH funding

2008 (2), 2025 (2), P50MH080215 (2), R01MH053932 (2), R34MH100468 (2), R61AT009988 (2), 1IK2RX003395 (1), 2005 (1), 5SC1MH090599 (1), F32MH129076 (1), K01MH072952 (1), K08MH094441 (1), K22MH074945 (1), K23AT004432 (1), K23MH108707 (1)